BIOMAT Database Logo BIOMAT Database Logo

Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells. 2010

Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama-city, Toyama, Japan.

Despite improvements in chemotherapy and surgery in the treatment of osteosarcoma (OS), satisfactory results are still difficult to achieve. Novel therapeutic modalities need to be developed for osteosarcoma treatment. The combined effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and ionizing radiation (IR) on human OS cells were investigated. IR and TRAIL treatment synergistically decreased the cell viability and enhanced apoptosis in OS cell lines. IR pretreatment enhances TRAIL-induced Bid and caspase-3 activations. Decreases in the expression levels of the antiapoptotic proteins c-FLIP and XIAP also associated with apoptosis enhancement. Furthermore, IR pretreatment enhanced DR4 and DR5 expressions at the transcription stage. These results can become the basic lines of evidence for the future treatment of OS using TRAIL with IR.

UI MeSH Term Description Entries
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Isoproterenol Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Embryonic Kidney Cells through Death Receptor 5 up-Regulation.
January 2016, Korean circulation journal,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.
February 2012, Cancer science,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
November 2005, Carcinogenesis,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
December 2011, The Journal of biological chemistry,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer.
September 2014, The American Journal of dermatopathology,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
October 2002, Apoptosis : an international journal on programmed cell death,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
October 2004, Cancer gene therapy,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Extracellular acidity enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis via DR5 in gastric cancer cells.
September 2018, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
November 2005, The Journal of investigative dermatology,
Takeshi Hori, and Takashi Kondo, and Masahiko Kanamori, and Yoshiaki Tabuchi, and Ryohei Ogawa, and Qing-Li Zhao, and Kanwal Ahmed, and Taketoshi Yasuda, and Shoji Seki, and Kayo Suzuki, and Tomoatsu Kimura
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
February 2006, Cancer research,
Copied contents to your clipboard!